In systemic circulation, elevated Gal-3 serum level was reported in metastatic prostate cancer patients in a pre-pilot study, implying a possible complementary diagnostic marker together with the PSA test [10]. The gene discussed is KLK3; the disease is metastatic prostate carcinoma.